FindTrial
Sign In

Clinical trial to evaluate the effect of somraji taila in pama kushtha

Clinical study to evaluate the Efficacy of SomrajiTaila in Pamkushtha

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025869
Enrollment
50
Registered
2020-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: somraji taila: Thin layer of somraji taila should be applied on affected area for 7 days. There are total 4 follow up. 1st & 2nd follow up will be at the interval of every 7 days, then

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age - 5 to 16 years Children diagnosed as the case of Pama Kushtha with the presenting symptoms.

Exclusion criteria

Exclusion criteria: Below the age of 5 year and above 16 year. Kushtha other than Pama.

Design outcomes

Primary

MeasureTime frame
To Evaluate the efficacy of Somraji Taila in Pama kushtha, subjectively all sign and symptoms were given grading depending upon their severity.Timepoint: 8 weeks—

Secondary

MeasureTime frame
Exacerbation in sign and symptoms.Timepoint: 7 days.—

Countries

India

Contacts

Public ContactDr Reena Pandey

Rishikul Campus, Uttarakhand ayurveda University, Haridwar

reenapandey1317@gmail.com9456131155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026